Home / Investors Information / EDAP TMS SA to Raise $5.625 Million in Registered Direct Offering Read more about EDAP TMS SA to Raise $5.625 Million in Registered Direct Offering EDAP Reports Fourth Quarter Revenue Up 23% Sequentially Read more about EDAP Reports Fourth Quarter Revenue Up 23% Sequentially EDAP Partners With PanAm HIFU to Offer Ablatherm(R)-HIFU to Prostate Cancer Patients in Cancun, Mexico Read more about EDAP Partners With PanAm HIFU to Offer Ablatherm(R)-HIFU to Prostate Cancer Patients in Cancun, Mexico EDAP Schedules Webcast and Conference Call for Fourth Quarter and Full Year 2011 Results Read more about EDAP Schedules Webcast and Conference Call for Fourth Quarter and Full Year 2011 Results EDAP Ablatherm-HIFU Presentations Receive "Best Poster" Awards at the 27th Annual European Association of Urology Congress Read more about EDAP Ablatherm-HIFU Presentations Receive "Best Poster" Awards at the 27th Annual European Association of Urology Congress EDAP Reports U.S. Sales of Sonolith i-move Read more about EDAP Reports U.S. Sales of Sonolith i-move EDAP Regains Ablatherm(R)-HIFU Distribution Rights in Canada and Caribbean Read more about EDAP Regains Ablatherm(R)-HIFU Distribution Rights in Canada and Caribbean EDAP Streamlines Capital Structure Read more about EDAP Streamlines Capital Structure EDAP Confirms Robotic Ablatherm(R)-HIFU Position as 'Must Have' Complement to Prostate Cancer Surgery at Two Major Scientific Conferences Read more about EDAP Confirms Robotic Ablatherm(R)-HIFU Position as 'Must Have' Complement to Prostate Cancer Surgery at Two Major Scientific Conferences EDAP Reports Third Quarter 2011 Financial Results Read more about EDAP Reports Third Quarter 2011 Financial Results Pagination First page « First Previous page ‹ Previous … Page 30 Page 31 Page 32 Page 33 Current page 34 Page 35 Page 36 Page 37 Page 38 … Next page Next › Last page Last » Subscribe to
EDAP TMS SA to Raise $5.625 Million in Registered Direct Offering Read more about EDAP TMS SA to Raise $5.625 Million in Registered Direct Offering
EDAP Reports Fourth Quarter Revenue Up 23% Sequentially Read more about EDAP Reports Fourth Quarter Revenue Up 23% Sequentially
EDAP Partners With PanAm HIFU to Offer Ablatherm(R)-HIFU to Prostate Cancer Patients in Cancun, Mexico Read more about EDAP Partners With PanAm HIFU to Offer Ablatherm(R)-HIFU to Prostate Cancer Patients in Cancun, Mexico
EDAP Schedules Webcast and Conference Call for Fourth Quarter and Full Year 2011 Results Read more about EDAP Schedules Webcast and Conference Call for Fourth Quarter and Full Year 2011 Results
EDAP Ablatherm-HIFU Presentations Receive "Best Poster" Awards at the 27th Annual European Association of Urology Congress Read more about EDAP Ablatherm-HIFU Presentations Receive "Best Poster" Awards at the 27th Annual European Association of Urology Congress
EDAP Reports U.S. Sales of Sonolith i-move Read more about EDAP Reports U.S. Sales of Sonolith i-move
EDAP Regains Ablatherm(R)-HIFU Distribution Rights in Canada and Caribbean Read more about EDAP Regains Ablatherm(R)-HIFU Distribution Rights in Canada and Caribbean
EDAP Confirms Robotic Ablatherm(R)-HIFU Position as 'Must Have' Complement to Prostate Cancer Surgery at Two Major Scientific Conferences Read more about EDAP Confirms Robotic Ablatherm(R)-HIFU Position as 'Must Have' Complement to Prostate Cancer Surgery at Two Major Scientific Conferences
EDAP Reports Third Quarter 2011 Financial Results Read more about EDAP Reports Third Quarter 2011 Financial Results
